Effects of high-intensity interval training compared with resistance training in prostate cancer patients undergoing radiotherapy: a randomized controlled trial
Background Exercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing radiation therapy (RT). However, the optimal modality of the exercise programs have not been yet determined. The aim of this randomized contro...
Saved in:
| Published in | Prostate cancer and prostatic diseases Vol. 24; no. 1; pp. 156 - 165 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
01.03.2021
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Background
Exercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing radiation therapy (RT). However, the optimal modality of the exercise programs have not been yet determined. The aim of this randomized controlled trial was to investigate the effects of high-intensity interval training (HIIT) and resistance training (RES) compared to usual care (UC) on cancer-treatment-related fatigue (CTRF) (primary outcome), quality of life, depression, daytime sleepiness, insomnia, sleep quality, functional exercise capacity and executive function in PCa patients during RT.
Methods
PCa patients undergoing RT with or without ADT were randomized in HIIT, RES or UC. Both exercise programs included three sessions per week during 5–8 weeks. HIIT consisted of 8–15 × 60 s intervals (≥85% maximal heart rate). RES was performed with 1–3 sets of 8–12 repetitions for each large muscle groups. The primary outcome was changed in CTRF measured with the Functional Assessment of Chronic Illness Therapy–Fatigue.
Results
Seventy-two subjects (69.1 ± 8.2 years) completed the study. No exercise-related adverse events occurred. HIIT (
p
= 0.012) and RES (
p
= 0.039) training attenuated increases in CTRF compared to UC. Functional exercise capacity, evaluated by the 6-min walk test, increased after HIIT (
p
= 0 = 0.43) and RES (
p
= 0.041) compared to UC (+0.1%). No other secondary variables were different between groups.
Conclusions
Both intervention groups displayed beneficial effects on CTRF and functional exercise capacity in PCa patients undergoing RT. In addition, HIIT and RES are both safe with an excellent attendance rate to the exercise sessions. |
|---|---|
| AbstractList | Exercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing radiation therapy (RT). However, the optimal modality of the exercise programs have not been yet determined. The aim of this randomized controlled trial was to investigate the effects of high-intensity interval training (HIIT) and resistance training (RES) compared to usual care (UC) on cancer-treatment-related fatigue (CTRF) (primary outcome), quality of life, depression, daytime sleepiness, insomnia, sleep quality, functional exercise capacity and executive function in PCa patients during RT.BACKGROUNDExercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing radiation therapy (RT). However, the optimal modality of the exercise programs have not been yet determined. The aim of this randomized controlled trial was to investigate the effects of high-intensity interval training (HIIT) and resistance training (RES) compared to usual care (UC) on cancer-treatment-related fatigue (CTRF) (primary outcome), quality of life, depression, daytime sleepiness, insomnia, sleep quality, functional exercise capacity and executive function in PCa patients during RT.PCa patients undergoing RT with or without ADT were randomized in HIIT, RES or UC. Both exercise programs included three sessions per week during 5-8 weeks. HIIT consisted of 8-15 × 60 s intervals (≥85% maximal heart rate). RES was performed with 1-3 sets of 8-12 repetitions for each large muscle groups. The primary outcome was changed in CTRF measured with the Functional Assessment of Chronic Illness Therapy-Fatigue.METHODSPCa patients undergoing RT with or without ADT were randomized in HIIT, RES or UC. Both exercise programs included three sessions per week during 5-8 weeks. HIIT consisted of 8-15 × 60 s intervals (≥85% maximal heart rate). RES was performed with 1-3 sets of 8-12 repetitions for each large muscle groups. The primary outcome was changed in CTRF measured with the Functional Assessment of Chronic Illness Therapy-Fatigue.Seventy-two subjects (69.1 ± 8.2 years) completed the study. No exercise-related adverse events occurred. HIIT (p = 0.012) and RES (p = 0.039) training attenuated increases in CTRF compared to UC. Functional exercise capacity, evaluated by the 6-min walk test, increased after HIIT (p = 0 = 0.43) and RES (p = 0.041) compared to UC (+0.1%). No other secondary variables were different between groups.RESULTSSeventy-two subjects (69.1 ± 8.2 years) completed the study. No exercise-related adverse events occurred. HIIT (p = 0.012) and RES (p = 0.039) training attenuated increases in CTRF compared to UC. Functional exercise capacity, evaluated by the 6-min walk test, increased after HIIT (p = 0 = 0.43) and RES (p = 0.041) compared to UC (+0.1%). No other secondary variables were different between groups.Both intervention groups displayed beneficial effects on CTRF and functional exercise capacity in PCa patients undergoing RT. In addition, HIIT and RES are both safe with an excellent attendance rate to the exercise sessions.CONCLUSIONSBoth intervention groups displayed beneficial effects on CTRF and functional exercise capacity in PCa patients undergoing RT. In addition, HIIT and RES are both safe with an excellent attendance rate to the exercise sessions. BackgroundExercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing radiation therapy (RT). However, the optimal modality of the exercise programs have not been yet determined. The aim of this randomized controlled trial was to investigate the effects of high-intensity interval training (HIIT) and resistance training (RES) compared to usual care (UC) on cancer-treatment-related fatigue (CTRF) (primary outcome), quality of life, depression, daytime sleepiness, insomnia, sleep quality, functional exercise capacity and executive function in PCa patients during RT.MethodsPCa patients undergoing RT with or without ADT were randomized in HIIT, RES or UC. Both exercise programs included three sessions per week during 5–8 weeks. HIIT consisted of 8–15 × 60 s intervals (≥85% maximal heart rate). RES was performed with 1–3 sets of 8–12 repetitions for each large muscle groups. The primary outcome was changed in CTRF measured with the Functional Assessment of Chronic Illness Therapy–Fatigue.ResultsSeventy-two subjects (69.1 ± 8.2 years) completed the study. No exercise-related adverse events occurred. HIIT (p = 0.012) and RES (p = 0.039) training attenuated increases in CTRF compared to UC. Functional exercise capacity, evaluated by the 6-min walk test, increased after HIIT (p = 0 = 0.43) and RES (p = 0.041) compared to UC (+0.1%). No other secondary variables were different between groups.ConclusionsBoth intervention groups displayed beneficial effects on CTRF and functional exercise capacity in PCa patients undergoing RT. In addition, HIIT and RES are both safe with an excellent attendance rate to the exercise sessions. Exercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing radiation therapy (RT). However, the optimal modality of the exercise programs have not been yet determined. The aim of this randomized controlled trial was to investigate the effects of high-intensity interval training (HIIT) and resistance training (RES) compared to usual care (UC) on cancer-treatment-related fatigue (CTRF) (primary outcome), quality of life, depression, daytime sleepiness, insomnia, sleep quality, functional exercise capacity and executive function in PCa patients during RT. PCa patients undergoing RT with or without ADT were randomized in HIIT, RES or UC. Both exercise programs included three sessions per week during 5-8 weeks. HIIT consisted of 8-15 × 60 s intervals ([greater than or equal to]85% maximal heart rate). RES was performed with 1-3 sets of 8-12 repetitions for each large muscle groups. The primary outcome was changed in CTRF measured with the Functional Assessment of Chronic Illness Therapy-Fatigue. Seventy-two subjects (69.1 [plus or minus] 8.2 years) completed the study. No exercise-related adverse events occurred. HIIT (p = 0.012) and RES (p = 0.039) training attenuated increases in CTRF compared to UC. Functional exercise capacity, evaluated by the 6-min walk test, increased after HIIT (p = 0 = 0.43) and RES (p = 0.041) compared to UC (+0.1%). No other secondary variables were different between groups. Both intervention groups displayed beneficial effects on CTRF and functional exercise capacity in PCa patients undergoing RT. In addition, HIIT and RES are both safe with an excellent attendance rate to the exercise sessions. Background Exercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing radiation therapy (RT). However, the optimal modality of the exercise programs have not been yet determined. The aim of this randomized controlled trial was to investigate the effects of high-intensity interval training (HIIT) and resistance training (RES) compared to usual care (UC) on cancer-treatment-related fatigue (CTRF) (primary outcome), quality of life, depression, daytime sleepiness, insomnia, sleep quality, functional exercise capacity and executive function in PCa patients during RT. Methods PCa patients undergoing RT with or without ADT were randomized in HIIT, RES or UC. Both exercise programs included three sessions per week during 5-8 weeks. HIIT consisted of 8-15 × 60 s intervals ([greater than or equal to]85% maximal heart rate). RES was performed with 1-3 sets of 8-12 repetitions for each large muscle groups. The primary outcome was changed in CTRF measured with the Functional Assessment of Chronic Illness Therapy-Fatigue. Results Seventy-two subjects (69.1 [plus or minus] 8.2 years) completed the study. No exercise-related adverse events occurred. HIIT (p = 0.012) and RES (p = 0.039) training attenuated increases in CTRF compared to UC. Functional exercise capacity, evaluated by the 6-min walk test, increased after HIIT (p = 0 = 0.43) and RES (p = 0.041) compared to UC (+0.1%). No other secondary variables were different between groups. Conclusions Both intervention groups displayed beneficial effects on CTRF and functional exercise capacity in PCa patients undergoing RT. In addition, HIIT and RES are both safe with an excellent attendance rate to the exercise sessions. Background Exercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing radiation therapy (RT). However, the optimal modality of the exercise programs have not been yet determined. The aim of this randomized controlled trial was to investigate the effects of high-intensity interval training (HIIT) and resistance training (RES) compared to usual care (UC) on cancer-treatment-related fatigue (CTRF) (primary outcome), quality of life, depression, daytime sleepiness, insomnia, sleep quality, functional exercise capacity and executive function in PCa patients during RT. Methods PCa patients undergoing RT with or without ADT were randomized in HIIT, RES or UC. Both exercise programs included three sessions per week during 5–8 weeks. HIIT consisted of 8–15 × 60 s intervals (≥85% maximal heart rate). RES was performed with 1–3 sets of 8–12 repetitions for each large muscle groups. The primary outcome was changed in CTRF measured with the Functional Assessment of Chronic Illness Therapy–Fatigue. Results Seventy-two subjects (69.1 ± 8.2 years) completed the study. No exercise-related adverse events occurred. HIIT ( p = 0.012) and RES ( p = 0.039) training attenuated increases in CTRF compared to UC. Functional exercise capacity, evaluated by the 6-min walk test, increased after HIIT ( p = 0 = 0.43) and RES ( p = 0.041) compared to UC (+0.1%). No other secondary variables were different between groups. Conclusions Both intervention groups displayed beneficial effects on CTRF and functional exercise capacity in PCa patients undergoing RT. In addition, HIIT and RES are both safe with an excellent attendance rate to the exercise sessions. Exercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing radiation therapy (RT). However, the optimal modality of the exercise programs have not been yet determined. The aim of this randomized controlled trial was to investigate the effects of high-intensity interval training (HIIT) and resistance training (RES) compared to usual care (UC) on cancer-treatment-related fatigue (CTRF) (primary outcome), quality of life, depression, daytime sleepiness, insomnia, sleep quality, functional exercise capacity and executive function in PCa patients during RT. PCa patients undergoing RT with or without ADT were randomized in HIIT, RES or UC. Both exercise programs included three sessions per week during 5-8 weeks. HIIT consisted of 8-15 × 60 s intervals (≥85% maximal heart rate). RES was performed with 1-3 sets of 8-12 repetitions for each large muscle groups. The primary outcome was changed in CTRF measured with the Functional Assessment of Chronic Illness Therapy-Fatigue. Seventy-two subjects (69.1 ± 8.2 years) completed the study. No exercise-related adverse events occurred. HIIT (p = 0.012) and RES (p = 0.039) training attenuated increases in CTRF compared to UC. Functional exercise capacity, evaluated by the 6-min walk test, increased after HIIT (p = 0 = 0.43) and RES (p = 0.041) compared to UC (+0.1%). No other secondary variables were different between groups. Both intervention groups displayed beneficial effects on CTRF and functional exercise capacity in PCa patients undergoing RT. In addition, HIIT and RES are both safe with an excellent attendance rate to the exercise sessions. |
| Audience | Academic |
| Author | Reychler, Gregory Renard, Laurette Geets, Xavier Caty, Gilles Vancraeynest, David Tombal, Bertrand Piraux, Elise |
| Author_xml | – sequence: 1 givenname: Elise orcidid: 0000-0003-3841-2134 surname: Piraux fullname: Piraux, Elise email: elise.piraux@uclouvain.be organization: Pôle de Neuro Musculo Skeletal Lab, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Pôle de Pneumologie, ORL & Dermatologie, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Clinical Neuroscience, Institute of Neurosciences, Université catholique de Louvain – sequence: 2 givenname: Gilles surname: Caty fullname: Caty, Gilles organization: Pôle de Neuro Musculo Skeletal Lab, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Clinical Neuroscience, Institute of Neurosciences, Université catholique de Louvain, Service de médecine physique et réadaptation, Cliniques universitaires Saint-Luc – sequence: 3 givenname: Laurette surname: Renard fullname: Renard, Laurette organization: Department of Radiation Oncology, Cliniques universitaires Saint-Luc – sequence: 4 givenname: David surname: Vancraeynest fullname: Vancraeynest, David organization: Pôle de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Division of Cardiology, Cliniques universitaires Saint-Luc – sequence: 5 givenname: Bertrand surname: Tombal fullname: Tombal, Bertrand organization: Service d’urologie, Cliniques universitaires Saint-Luc – sequence: 6 givenname: Xavier surname: Geets fullname: Geets, Xavier organization: Department of Radiation Oncology, Cliniques universitaires Saint-Luc, Molecular Imaging, Radiotherapy and Oncology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain – sequence: 7 givenname: Gregory orcidid: 0000-0002-7674-1150 surname: Reychler fullname: Reychler, Gregory organization: Pôle de Pneumologie, ORL & Dermatologie, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Haute Ecole Léonard de Vinci, PARNASSE-ISEI, Secteur de kinésithérapie, Cliniques universitaires Saint-Luc, Service de Pneumologie, Cliniques universitaires Saint-Luc |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32719354$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kltrFTEQxxep2It-AF8kIIgvW3PfrG-l1AsUfNHnkM0mZ1OyyTHJVo6fxo9qllM9tqiEkEny-88MM3PaHIUYTNM8R_AcQSLeZIpIj1qIYd2sb_mj5gTRjreMQ3FUbcJZ2wmGj5vTnG8ghD3q4ZPmmOAO9YTRk-bHlbVGlwyiBZPbTK0LxYTsyg6sVrpVHpSkXHBhA3SctyqZEXxzZQLJZJeLCtocCBfANsX6WgzQ61cCW1WcCTXCEkaTNnHFkhpdLJNJart7C1S9hzHO7nt1rWMoKXpfzZKc8k-bx1b5bJ7dnWfNl3dXny8_tNef3n-8vLhuNUOktD22GOmhs4MVmiOOCBGMC22p1mpAlGFM6WgIGSEdueCUcCwE6Xs-YDp2kJw1r_d-a_5fF5OLnF3WxnsVTFyyxBQLyNcCVvTlA_QmLinU7CRmsCOMMyYO1EZ5I12wsVZJr07lBWe85xSyrlLnf6HqGs3sai2MdfX9nuDVH4LJKF-mHP1SXAz5PvjiLstlmM0ot8nNKu3kr95XAO0BXTuWk7G_EQTlOl9yP1-yzpdc50vyqukeaLSrzXZr05Tz_1XivTLXKGFj0qFo_xb9BPki5Ag |
| CitedBy_id | crossref_primary_10_1016_j_euros_2022_07_008 crossref_primary_10_1249_MSS_0000000000003191 crossref_primary_10_3390_healthcare10091795 crossref_primary_10_3390_ijerph182010973 crossref_primary_10_1371_journal_pone_0287152 crossref_primary_10_1016_j_ijrobp_2021_06_034 crossref_primary_10_1002_cam4_7179 crossref_primary_10_3389_fphys_2025_1543217 crossref_primary_10_3390_ijms22094469 crossref_primary_10_2519_jospt_2023_11251 crossref_primary_10_1016_j_urolonc_2022_11_016 crossref_primary_10_3389_fonc_2024_1393902 crossref_primary_10_1155_2022_9032534 crossref_primary_10_1002_14651858_CD015517 crossref_primary_10_1002_14651858_CD015518 crossref_primary_10_1016_j_jpsychores_2024_111652 crossref_primary_10_3389_fneur_2024_1421469 crossref_primary_10_3390_cancers16244286 crossref_primary_10_1016_j_jpsychores_2023_111470 crossref_primary_10_1097_JS9_0000000000000982 crossref_primary_10_1002_cam4_6753 crossref_primary_10_1007_s00520_023_08103_9 crossref_primary_10_1016_j_ijchp_2023_100433 crossref_primary_10_1016_j_jsams_2023_09_020 crossref_primary_10_1186_s12957_022_02807_8 crossref_primary_10_1016_j_lfs_2021_119798 crossref_primary_10_1136_bjsports_2024_108163 crossref_primary_10_1001_jamanetworkopen_2024_37964 crossref_primary_10_1016_j_semradonc_2021_11_004 crossref_primary_10_1002_pros_24285 crossref_primary_10_1038_s41391_024_00801_7 crossref_primary_10_3390_cancers16122241 |
| Cites_doi | 10.1188/04.ONF.735-746 10.1016/S0885-3924(96)00274-6 10.1007/s11764-015-0490-7 10.1200/JCO.2009.23.2488 10.1016/S0885-3924(02)00529-8 10.1200/JCO.2003.09.534 10.1002/(SICI)1097-0142(20000201)88:3<674::AID-CNCR26>3.0.CO;2-R 10.1016/0165-1781(89)90047-4 10.1200/JCO.2007.15.4963 10.1093/annonc/mdv222 10.1016/j.jpainsymman.2007.07.007 10.1016/j.jclinepi.2010.03.004 10.1249/MSS.0000000000002116 10.1136/bjsports-2013-092576 10.1002/cncr.31024 10.1097/COC.0b013e3181e841ec 10.1093/sleep/34.2.171 10.1200/JCO.1993.11.3.570 10.1016/j.jmir.2018.02.056 10.1200/JCO.2006.08.2024 10.1007/s00520-011-1167-z 10.1007/s11764-019-00743-3 10.1177/014662167700100306 10.1113/jphysiol.2011.224725 10.1002/pon.3521 10.1016/j.apmr.2007.08.110 10.1007/s00520-018-4239-5 10.1016/S0360-3016(99)00232-1 10.1093/jnci/92.19.1582 10.1002/cncr.20378 10.1016/j.eururo.2015.10.047 10.1183/09031936.00150314 10.1093/annonc/mdr034 10.1016/S0022-5347(05)65679-0 10.1159/000487081 10.1016/j.eururo.2017.02.019 10.1111/j.1365-2354.2009.01083.x 10.1001/jamaoncol.2016.6914 10.1177/2050312120922657 10.1093/sleep/14.6.540 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer Nature Limited 2020 COPYRIGHT 2021 Nature Publishing Group The Author(s), under exclusive licence to Springer Nature Limited 2020. |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature Limited 2020 – notice: COPYRIGHT 2021 Nature Publishing Group – notice: The Author(s), under exclusive licence to Springer Nature Limited 2020. |
| DBID | AAYXX CITATION NPM 3V. 7TO 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P M7Z P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1038/s41391-020-0259-6 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Biological Science Database Biochemistry Abstracts 1 Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed ProQuest Central Student Oncogenes and Growth Factors Abstracts Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Biochemistry Abstracts 1 Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest Central Student PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central - New (Subscription) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1476-5608 |
| EndPage | 165 |
| ExternalDocumentID | A656964057 32719354 10_1038_s41391_020_0259_6 |
| Genre | Journal Article |
| GeographicLocations | Belgium |
| GeographicLocations_xml | – name: Belgium |
| GrantInformation_xml | – fundername: Fonds De La Recherche Scientifique - FNRS (Belgian National Fund for Scientific Research) funderid: https://doi.org/10.13039/501100002661 – fundername: Institut de Recherche Expérimentale et Clinique (Université catholique de Louvain, Brussels, Belgium) |
| GroupedDBID | --- -Q- 0R~ 123 29P 2WC 36B 39C 3V. 4.4 406 53G 70F 7X7 88E 8AO 8C1 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAYZH AAZLF ABAKF ABAWZ ABDBF ABJNI ABUWG ABZZP ACAOD ACGFS ACIWK ACKTT ACPRK ACRQY ACUHS ACZOJ ADBBV ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AXYYD B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DU5 E3Z EAD EAP EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL ESX F5P FDQFY FERAY FIGPU FIZPM FYUFA HCIFZ HMCUK HZ~ IAO IHR IHW INH INR ITC IWAJR JSO JZLTJ KQ8 M1P M7P NAO NQJWS O9- OK1 OVD P2P PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UDS UKHRP W2D ~8M AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT NPM AEIIB PMFND 7TO 7XB 8FD 8FE 8FH 8FK ABRTQ AZQEC DWQXO FR3 GNUQQ H94 K9. LK8 M7Z P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 |
| ID | FETCH-LOGICAL-c513t-92f21cb7fbf8c6161338568cf4ccab1452244de33d04d6864362883996b24d703 |
| IEDL.DBID | 7X7 |
| ISSN | 1365-7852 1476-5608 |
| IngestDate | Mon Jul 21 10:30:09 EDT 2025 Sat Aug 23 12:54:23 EDT 2025 Tue Jun 17 21:11:02 EDT 2025 Tue Jun 10 20:24:09 EDT 2025 Thu May 22 21:22:43 EDT 2025 Thu Apr 03 07:09:37 EDT 2025 Thu Apr 24 22:54:01 EDT 2025 Tue Jul 01 03:42:14 EDT 2025 Fri Feb 21 02:38:04 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c513t-92f21cb7fbf8c6161338568cf4ccab1452244de33d04d6864362883996b24d703 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0003-3841-2134 0000-0002-7674-1150 |
| OpenAccessLink | http://hdl.handle.net/2078.1/232125 |
| PMID | 32719354 |
| PQID | 2507356558 |
| PQPubID | 27992 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_2428060919 proquest_journals_2507356558 gale_infotracmisc_A656964057 gale_infotracacademiconefile_A656964057 gale_healthsolutions_A656964057 pubmed_primary_32719354 crossref_primary_10_1038_s41391_020_0259_6 crossref_citationtrail_10_1038_s41391_020_0259_6 springer_journals_10_1038_s41391_020_0259_6 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-03-01 |
| PublicationDateYYYYMMDD | 2021-03-01 |
| PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England – name: Houndmills |
| PublicationTitle | Prostate cancer and prostatic diseases |
| PublicationTitleAbbrev | Prostate Cancer Prostatic Dis |
| PublicationTitleAlternate | Prostate Cancer Prostatic Dis |
| PublicationYear | 2021 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Zelefsky, Ginor, Fuks, Leibel (CR42) 1999; 45 Feng, Espina, Saligan (CR7) 2018; 94 Miaskowski, Paul, Cooper, Lee, Dodd, West (CR4) 2008; 35 LaVoy, Fagundes, Dantzer (CR37) 2016; 22 CR16 Campbell, Winters-Stone, Wiskemann, May, Schwartz, Courneya (CR32) 2019; 51 Storey, McLaren, Atkinson, Butcher, Liggatt, O’Dea (CR6) 2012; 23 Vena, Parker, Cunningham, Clark, McMillan (CR9) 2004; 31 Bacon, Giovannucci, Testa, Kawachi (CR2) 2001; 166 CR30 Mugele, Freitag, Wilhelmi, Yang, Cheng, Bloch (CR20) 2019; 13 Buysse, Reynolds, Monk, Berman, Kupfer (CR28) 1989; 28 Gogou, Tsilika, Parpa, Kouvaris, Damigos, Balafouta (CR10) 2015; 35 Hess, Chen (CR8) 2014; 23 Mustian, Alfano, Heckler, Kleckner, Kleckner, Leach (CR33) 2017; 3 Devin, Sax, Hughes, Jenkins, Aitken, Chambers (CR38) 2016; 10 Borg (CR22) 1982; 14 Taaffe, Newton, Spry, Joseph, Chambers, Gardiner (CR34) 2017; 72 Horgan, O’Donovan (CR40) 2018; 49 Kapur, Windsor, McCowan (CR43) 2010; 19 Bourke, Smith, Steed, Hooper, Carter, Catto (CR39) 2016; 69 Segal, Reid, Courneya, Malone, Parliament, Scott (CR36) 2003; 21 Truong, Berthelet, Lee, Petersen, Lim, Gaul (CR5) 2006; 13 Hojan, Kwiatkowska-Borowczyk, Leporowska, Gorecki, Ozga-Majchrzak, Milecki (CR15) 2016; 52 Yellen, Cella, Webster, Blendowski, Kaplan (CR23) 1997; 13 Segal, Reid, Courneya, Sigal, Kenny, Prud’Homme (CR13) 2009; 27 CR27 Galvão, Taaffe, Spry, Joseph, Newton (CR35) 2010; 28 Gonzalez, Small, Cases, Williams, Fishman, Jacobsen (CR44) 2018; 124 CR46 Cella, Eton, Lai, Peterman, Merkel (CR31) 2002; 24 Demark-Wahnefried, Peterson, McBride, Lipkus, Clipp (CR48) 2000; 88 Truong, Gaul, McDonald, Petersen, Jones, Alexander (CR14) 2011; 34 Eng, Pringle, Su, Shen, Mahler, Niu (CR19) 2018; 26 Courneya, Segal, Mackey, Gelmon, Reid, Friedenreich (CR45) 2007; 25 Radloff (CR25) 1977; 1 Johns (CR26) 1991; 14 Holland, Spruit, Troosters, Puhan, Pepin, Saey (CR29) 2014; 44 Murnane, Geary, Milne (CR47) 2012; 20 Miaskowski, Paul, Cooper, Lee, Dodd, West (CR41) 2011; 34 Weston, Wisloff, Coombes (CR17) 2014; 48 Potosky, Legler, Albertsen, Stanford, Gilliland, Hamilton (CR3) 2000; 92 Monga, Garber, Thornby, Vallbona, Kerrigan, Monga (CR12) 2007; 88 Gibala, Little, Macdonald, Hawley (CR18) 2012; 590 Cella, Tulsky, Gray, Sarafian, Linn, Bonomi (CR24) 1993; 11 Parker, Gillessen, Heidenreich, Horwich (CR1) 2015; 26 Windsor, Nicol, Potter (CR11) 2004; 101 Moher, Hopewell, Schulz, Montori, Gotzsche, Devereaux (CR21) 2010; 63 C Miaskowski (259_CR41) 2011; 34 U Monga (259_CR12) 2007; 88 D Moher (259_CR21) 2010; 63 A Murnane (259_CR47) 2012; 20 C Miaskowski (259_CR4) 2008; 35 KM Mustian (259_CR33) 2017; 3 L Eng (259_CR19) 2018; 26 CB Hess (259_CR8) 2014; 23 MJ Zelefsky (259_CR42) 1999; 45 SB Yellen (259_CR23) 1997; 13 S Horgan (259_CR40) 2018; 49 C Parker (259_CR1) 2015; 26 LS Radloff (259_CR25) 1977; 1 259_CR30 DF Cella (259_CR24) 1993; 11 EC LaVoy (259_CR37) 2016; 22 RJ Segal (259_CR13) 2009; 27 MW Johns (259_CR26) 1991; 14 DR Taaffe (259_CR34) 2017; 72 259_CR16 GA Borg (259_CR22) 1982; 14 AL Potosky (259_CR3) 2000; 92 P Gogou (259_CR10) 2015; 35 DJ Storey (259_CR6) 2012; 23 RJ Segal (259_CR36) 2003; 21 BD Gonzalez (259_CR44) 2018; 124 KS Courneya (259_CR45) 2007; 25 G Kapur (259_CR43) 2010; 19 D Cella (259_CR31) 2002; 24 CG Bacon (259_CR2) 2001; 166 LR Feng (259_CR7) 2018; 94 K Hojan (259_CR15) 2016; 52 AE Holland (259_CR29) 2014; 44 PT Truong (259_CR14) 2011; 34 KL Campbell (259_CR32) 2019; 51 C Vena (259_CR9) 2004; 31 KS Weston (259_CR17) 2014; 48 JL Devin (259_CR38) 2016; 10 W Demark-Wahnefried (259_CR48) 2000; 88 PT Truong (259_CR5) 2006; 13 L Bourke (259_CR39) 2016; 69 259_CR46 PM Windsor (259_CR11) 2004; 101 MJ Gibala (259_CR18) 2012; 590 H Mugele (259_CR20) 2019; 13 259_CR27 DJ Buysse (259_CR28) 1989; 28 DA Galvão (259_CR35) 2010; 28 |
| References_xml | – volume: 49 start-page: 207 year: 2018 end-page: 19 ident: CR40 article-title: The impact of exercise during radiation therapy for prostate cancer on fatigue and quality of life: a systematic review and meta-analysis publication-title: J Med Imaging Radiat Sci – volume: 31 start-page: 735 year: 2004 end-page: 46 ident: CR9 article-title: Sleep-wake disturbances in people with cancer part I: an overview of sleep, sleep regulation, and effects of disease and treatment publication-title: Oncol Nurs Forum – volume: 13 start-page: 3139 year: 2006 end-page: 46 ident: CR5 article-title: Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy publication-title: Can J Urol – volume: 72 start-page: 293 year: 2017 end-page: 9 ident: CR34 article-title: Effects of different exercise modalities on fatigue in prostate cancer patients undergoing androgen deprivation therapy: a year-long randomised controlled trial publication-title: Eur Urol. – ident: CR16 – volume: 48 start-page: 1227 year: 2014 end-page: 34 ident: CR17 article-title: High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis publication-title: Br J Sports Med – ident: CR30 – volume: 28 start-page: 193 year: 1989 end-page: 213 ident: CR28 article-title: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research publication-title: Psychiatry Res – volume: 34 start-page: 171 year: 2011 end-page: 9 ident: CR41 article-title: Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy publication-title: Sleep – volume: 20 start-page: 957 year: 2012 end-page: 62 ident: CR47 article-title: The exercise programming preferences and activity levels of cancer patients undergoing radiotherapy treatment publication-title: Support Care Cancer – volume: 23 start-page: 65 year: 2012 end-page: 72 ident: CR6 article-title: Clinically relevant fatigue in recurrence-free prostate cancer survivors publication-title: Ann Oncol – volume: 14 start-page: 540 year: 1991 end-page: 5 ident: CR26 article-title: A new method for measuring daytime sleepiness: the Epworth sleepiness scale publication-title: Sleep – volume: 34 start-page: 350 year: 2011 end-page: 5 ident: CR14 article-title: Prospective evaluation of a 12-week walking exercise program and its effect on fatigue in prostate cancer patients undergoing radical external beam radiotherapy publication-title: Am J Clin Oncol – volume: 1 start-page: 385 year: 1977 end-page: 401 ident: CR25 article-title: The CES-D scale: A self-report depression scale for research in the general population publication-title: Appl Psychol Meas – volume: 51 start-page: 2375 year: 2019 end-page: 90 ident: CR32 article-title: Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable publication-title: Med Sci Sports Exerc – volume: 26 start-page: v69 year: 2015 end-page: 77 ident: CR1 article-title: Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol – volume: 88 start-page: 1416 year: 2007 end-page: 22 ident: CR12 article-title: Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy publication-title: Arch Phys Med Rehabil – volume: 24 start-page: 547 year: 2002 end-page: 61 ident: CR31 article-title: Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales publication-title: J Pain Symptom Manag – volume: 44 start-page: 1428 year: 2014 end-page: 46 ident: CR29 article-title: An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease publication-title: Eur Respir J – volume: 13 start-page: 205 year: 2019 end-page: 23 ident: CR20 article-title: High-intensity interval training in the therapy and aftercare of cancer patients: a systematic review with meta-analysis publication-title: J Cancer Surviv – volume: 63 start-page: e1 year: 2010 end-page: 37 ident: CR21 article-title: CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials publication-title: J Clin Epidemiol – ident: CR27 – volume: 3 start-page: 961 year: 2017 end-page: 8 ident: CR33 article-title: Comparison of pharmaceutical, psychological, and exercise treatments for Cancer-Related Fatigue: a meta-analysis publication-title: JAMA Oncol – volume: 21 start-page: 1653 year: 2003 end-page: 9 ident: CR36 article-title: Resistance exercise in men receiving androgen deprivation therapy for prostate cancer publication-title: J Clin Oncol – volume: 19 start-page: 643 year: 2010 end-page: 7 ident: CR43 article-title: The effect of aerobic exercise on treatment-related acute toxicity in men receiving radical external beam radiotherapy for localised prostate cancer publication-title: Eur J Cancer Care (Engl) – volume: 10 start-page: 467 year: 2016 end-page: 79 ident: CR38 article-title: The influence of high-intensity compared with moderate-intensity exercise training on cardiorespiratory fitness and body composition in colorectal cancer survivors: a randomised controlled trial publication-title: J Cancer Surviv – volume: 92 start-page: 1582 year: 2000 end-page: 92 ident: CR3 article-title: Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study publication-title: J Natl Cancer Inst – ident: CR46 – volume: 25 start-page: 4396 year: 2007 end-page: 404 ident: CR45 article-title: Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial publication-title: J Clin Oncol – volume: 35 start-page: 632 year: 2008 end-page: 43 ident: CR4 article-title: Trajectories of fatigue in men with prostate cancer before, during, and after radiation therapy publication-title: J Pain Symptom Manag – volume: 14 start-page: 377 year: 1982 end-page: 81 ident: CR22 article-title: Psychophysical bases of perceived exertion publication-title: Med Sci Sports Exerc – volume: 35 start-page: 1771 year: 2015 end-page: 5 ident: CR10 article-title: The impact of radiotherapy on symptoms, anxiety and QoL in patients with cancer publication-title: Anticancer Res – volume: 124 start-page: 499 year: 2018 end-page: 506 ident: CR44 article-title: Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: the role of hot flashes and nocturia publication-title: Cancer – volume: 13 start-page: 63 year: 1997 end-page: 74 ident: CR23 article-title: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system publication-title: J Pain Symptom Manag – volume: 23 start-page: 841 year: 2014 end-page: 54 ident: CR8 article-title: Measuring psychosocial functioning in the radiation oncology clinic: a systematic review publication-title: Psychooncology – volume: 52 start-page: 489 year: 2016 end-page: 501 ident: CR15 article-title: Physical exercise for functional capacity, blood immune function, fatigue, and quality of life in high-risk prostate cancer patients during radiotherapy: a prospective, randomized clinical study publication-title: Eur J Phys Rehabil Med – volume: 45 start-page: 567 year: 1999 end-page: 70 ident: CR42 article-title: Efficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancer publication-title: Int J Radiat Oncol Biol Phys – volume: 69 start-page: 693 year: 2016 end-page: 703 ident: CR39 article-title: Exercise for men with prostate cancer: a systematic review and meta-analysis publication-title: Eur Urol – volume: 94 start-page: 363 year: 2018 end-page: 72 ident: CR7 article-title: Association of fatigue intensification with cognitive impairment during radiation therapy for prostate cancer publication-title: Oncology – volume: 11 start-page: 570 year: 1993 end-page: 9 ident: CR24 article-title: The Functional Assessment of Cancer Therapy scale: development and validation of the general measure publication-title: J Clin Oncol – volume: 166 start-page: 1804 year: 2001 end-page: 10 ident: CR2 article-title: The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer publication-title: J Urol – volume: 26 start-page: 3755 year: 2018 end-page: 63 ident: CR19 article-title: Patterns, perceptions, and perceived barriers to physical activity in adult cancer survivors publication-title: Support Care Cancer – volume: 28 start-page: 340 year: 2010 end-page: 7 ident: CR35 article-title: Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial publication-title: J Clin Oncol – volume: 88 start-page: 674 year: 2000 end-page: 84 ident: CR48 article-title: Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas publication-title: Cancer – volume: 27 start-page: 344 year: 2009 end-page: 51 ident: CR13 article-title: Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer publication-title: J Clin Oncol – volume: 101 start-page: 550 year: 2004 end-page: 7 ident: CR11 article-title: A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma publication-title: Cancer – volume: 590 start-page: 1077 year: 2012 end-page: 84 ident: CR18 article-title: Physiological adaptations to low-volume, high-intensity interval training in health and disease publication-title: J Physiol – volume: 22 start-page: 82 year: 2016 end-page: 93 ident: CR37 article-title: Exercise, inflammation, and fatigue in cancer survivors publication-title: Exerc Immunol Rev – volume: 31 start-page: 735 year: 2004 ident: 259_CR9 publication-title: Oncol Nurs Forum doi: 10.1188/04.ONF.735-746 – volume: 13 start-page: 63 year: 1997 ident: 259_CR23 publication-title: J Pain Symptom Manag doi: 10.1016/S0885-3924(96)00274-6 – volume: 13 start-page: 3139 year: 2006 ident: 259_CR5 publication-title: Can J Urol – volume: 14 start-page: 377 year: 1982 ident: 259_CR22 publication-title: Med Sci Sports Exerc – volume: 10 start-page: 467 year: 2016 ident: 259_CR38 publication-title: J Cancer Surviv doi: 10.1007/s11764-015-0490-7 – volume: 28 start-page: 340 year: 2010 ident: 259_CR35 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.23.2488 – volume: 24 start-page: 547 year: 2002 ident: 259_CR31 publication-title: J Pain Symptom Manag doi: 10.1016/S0885-3924(02)00529-8 – volume: 52 start-page: 489 year: 2016 ident: 259_CR15 publication-title: Eur J Phys Rehabil Med – volume: 21 start-page: 1653 year: 2003 ident: 259_CR36 publication-title: J Clin Oncol doi: 10.1200/JCO.2003.09.534 – volume: 88 start-page: 674 year: 2000 ident: 259_CR48 publication-title: Cancer doi: 10.1002/(SICI)1097-0142(20000201)88:3<674::AID-CNCR26>3.0.CO;2-R – volume: 28 start-page: 193 year: 1989 ident: 259_CR28 publication-title: Psychiatry Res doi: 10.1016/0165-1781(89)90047-4 – volume: 27 start-page: 344 year: 2009 ident: 259_CR13 publication-title: J Clin Oncol doi: 10.1200/JCO.2007.15.4963 – volume: 26 start-page: v69 year: 2015 ident: 259_CR1 publication-title: Ann Oncol doi: 10.1093/annonc/mdv222 – volume: 35 start-page: 632 year: 2008 ident: 259_CR4 publication-title: J Pain Symptom Manag doi: 10.1016/j.jpainsymman.2007.07.007 – volume: 63 start-page: e1 year: 2010 ident: 259_CR21 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2010.03.004 – volume: 51 start-page: 2375 year: 2019 ident: 259_CR32 publication-title: Med Sci Sports Exerc doi: 10.1249/MSS.0000000000002116 – volume: 22 start-page: 82 year: 2016 ident: 259_CR37 publication-title: Exerc Immunol Rev – volume: 48 start-page: 1227 year: 2014 ident: 259_CR17 publication-title: Br J Sports Med doi: 10.1136/bjsports-2013-092576 – volume: 124 start-page: 499 year: 2018 ident: 259_CR44 publication-title: Cancer doi: 10.1002/cncr.31024 – volume: 34 start-page: 350 year: 2011 ident: 259_CR14 publication-title: Am J Clin Oncol doi: 10.1097/COC.0b013e3181e841ec – volume: 34 start-page: 171 year: 2011 ident: 259_CR41 publication-title: Sleep doi: 10.1093/sleep/34.2.171 – volume: 11 start-page: 570 year: 1993 ident: 259_CR24 publication-title: J Clin Oncol doi: 10.1200/JCO.1993.11.3.570 – volume: 49 start-page: 207 year: 2018 ident: 259_CR40 publication-title: J Med Imaging Radiat Sci doi: 10.1016/j.jmir.2018.02.056 – volume: 25 start-page: 4396 year: 2007 ident: 259_CR45 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.08.2024 – volume: 20 start-page: 957 year: 2012 ident: 259_CR47 publication-title: Support Care Cancer doi: 10.1007/s00520-011-1167-z – volume: 13 start-page: 205 year: 2019 ident: 259_CR20 publication-title: J Cancer Surviv doi: 10.1007/s11764-019-00743-3 – volume: 1 start-page: 385 year: 1977 ident: 259_CR25 publication-title: Appl Psychol Meas doi: 10.1177/014662167700100306 – volume: 590 start-page: 1077 year: 2012 ident: 259_CR18 publication-title: J Physiol doi: 10.1113/jphysiol.2011.224725 – volume: 23 start-page: 841 year: 2014 ident: 259_CR8 publication-title: Psychooncology doi: 10.1002/pon.3521 – ident: 259_CR46 – volume: 88 start-page: 1416 year: 2007 ident: 259_CR12 publication-title: Arch Phys Med Rehabil doi: 10.1016/j.apmr.2007.08.110 – ident: 259_CR27 – volume: 26 start-page: 3755 year: 2018 ident: 259_CR19 publication-title: Support Care Cancer doi: 10.1007/s00520-018-4239-5 – volume: 45 start-page: 567 year: 1999 ident: 259_CR42 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/S0360-3016(99)00232-1 – volume: 92 start-page: 1582 year: 2000 ident: 259_CR3 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.19.1582 – ident: 259_CR30 – volume: 35 start-page: 1771 year: 2015 ident: 259_CR10 publication-title: Anticancer Res – volume: 101 start-page: 550 year: 2004 ident: 259_CR11 publication-title: Cancer doi: 10.1002/cncr.20378 – volume: 69 start-page: 693 year: 2016 ident: 259_CR39 publication-title: Eur Urol doi: 10.1016/j.eururo.2015.10.047 – volume: 44 start-page: 1428 year: 2014 ident: 259_CR29 publication-title: Eur Respir J doi: 10.1183/09031936.00150314 – volume: 23 start-page: 65 year: 2012 ident: 259_CR6 publication-title: Ann Oncol doi: 10.1093/annonc/mdr034 – volume: 166 start-page: 1804 year: 2001 ident: 259_CR2 publication-title: J Urol doi: 10.1016/S0022-5347(05)65679-0 – volume: 94 start-page: 363 year: 2018 ident: 259_CR7 publication-title: Oncology doi: 10.1159/000487081 – volume: 72 start-page: 293 year: 2017 ident: 259_CR34 publication-title: Eur Urol. doi: 10.1016/j.eururo.2017.02.019 – volume: 19 start-page: 643 year: 2010 ident: 259_CR43 publication-title: Eur J Cancer Care (Engl) doi: 10.1111/j.1365-2354.2009.01083.x – volume: 3 start-page: 961 year: 2017 ident: 259_CR33 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2016.6914 – ident: 259_CR16 doi: 10.1177/2050312120922657 – volume: 14 start-page: 540 year: 1991 ident: 259_CR26 publication-title: Sleep doi: 10.1093/sleep/14.6.540 |
| SSID | ssj0009190 |
| Score | 2.4315796 |
| Snippet | Background
Exercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing... Exercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing radiation... Background Exercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing... BackgroundExercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing... |
| SourceID | proquest gale pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 156 |
| SubjectTerms | 692/308/409 692/699/2768/589/466 692/699/67/1059 692/699/67/589/466 Biomedical and Life Sciences Biomedicine Cancer Cancer patients Cancer Research Cancer therapies Care and treatment Chronic diseases Clinical trials Comparative analysis Depression, Mental Executive function Fatigue Heart beat Heart rate Insomnia Interval training Muscles Physical training Prostate cancer Quality of life Radiation Radiation therapy Radiotherapy Resistance training Side effects Sleep and wakefulness Sleep disorders Sleepiness Strength training Weight training |
| Title | Effects of high-intensity interval training compared with resistance training in prostate cancer patients undergoing radiotherapy: a randomized controlled trial |
| URI | https://link.springer.com/article/10.1038/s41391-020-0259-6 https://www.ncbi.nlm.nih.gov/pubmed/32719354 https://www.proquest.com/docview/2507356558 https://www.proquest.com/docview/2428060919 |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdbC2MvY99z13UaDAYborYs2_JeRlIayqBhjBXyJqwPD0Nnp3H60P01-1N3J8vJUlhfHAedbIs7nX7SfRHyPrfCiVgXDNObMdh_caZNbVgVuzLmmlfan3ecz_OzC_F1kS3CgVsf3CpHnegVte0MnpEfw1JdpIA-MvllecWwahRaV0MJjftkH1OXoVQXi2KbdDcp4zHuqpAZH62aqTzuQXmjzw9snmDVL1m-sy7d1s7_LE-37KV-GZo9Jo8CfqSTgeFPyD3XPiUPzoOF_Bn5M6Qj7mlXU0xFzJrBR319Qxvv3gidx7IQdHRAp3gaS2HjjWASpGBL0bR0iXEhgEipwaYVDZlYe4rhZ6ufHZKtKtuEUK6bz7SC_63tfjW_4dHBF_4Sbn2FkOfkYnb64-SMhSoMzGRJumYlr3lidFHrWpocACJsarNcmloA83WCGdmFsC5NbSxsLgHh-ArGsI_SXFhQKC_IXtu17hWhQseJcUJWuYyFEbYSoqgBkkhnXFVyG5F45IEyIUU5DvhSeVN5KtXANgVsU8g2lUfk46bLcsjPcRfxW2SsGkJMN3NbTQDUljlC14h88BQ4u-HNpgpBCvD9mCdrh_JwhxJmpdltHoVHBa3Qq60MR-Tdphl7oqdb67proBFo60bRjcjLQeg2A0t5AXg7ExH5NErh9uH_HfXB3Z_ymjzk6Kfj_eoOyd56de3eANBa6yM_m-AqT5Ijsj-ZTadz-J2ezr99_wsMAygx |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1da9RAcKgVtC_iZ41Wu4IiKKHJZpNsBJFSLVfb61MLfVuzm40E2uS8XJHz1_gL_I3ObJI7r2Df-paws5ssMzsfO18Ar5NCWBHo1KfyZj7aX9zXpjR-Htgs4Jrn2t13jI-T0an4ehafrcGfIReGwioHnugYddEYuiPfQVGdRqh9xPLT5IdPXaPIuzq00OjI4tDOf6LJ1n48-Iz4fcP5_peTvZHfdxXwTRxGMz_jJQ-NTktdSpOgwoNGWpxIUwrcjA6pwrgQhY2iIhBFIlFiu468aBdoLgo8ILjuLbgtIjyalJm-twwpycIsGPK8UhnzwYsayZ0WhQXFGKGxhlpG5icrcvCqNPhHHF7xzzqxt38f7vX6KtvtCOwBrNn6IdwZ9x75R_C7K3_csqZkVPrYr7qY-NmcVS6cEicPbSjYEPDO6PaXoaFPyitS3RKiqtmE8lBQA2aGhqasr_zaMkp3m35vCGyaF1WfOjb_wHJ8r4vmovqFS_ex9-f46DqSPIbTG8HPE1ivm9o-BSZ0EBorZJ7IQBhR5EKkJapA0hqbZ7zwIBhwoExfEp02fK6caz6SqkObQrQpQptKPHi3mDLp6oFcB7xNiFVdSuuCl6hdVKKzhFRlD946COIm-GWT90kR-P9Ul2sFcmsFErmAWR0eiEf1XKhVyzPjwavFMM2kyLraNpcII8i3TqTrwWZHdIuNRTxF_T4WHrwfqHC5-H93_ez6X9mGu6OT8ZE6Ojg-fA4bnGKEXEzfFqzPppf2BSp5M_3SnSwG3276KP8Fxaxe8Q |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3batRA9FArFF_Ee2OrHUERlLDJZJJMBJHSurTWFh8s9G1MJhMJ1GS72SLr1_gdfp3nTCa7bsG-9W1DzsxmOPc5N4CXSSmMCIrUp_ZmPvpf3C90pf08MFnAC54X9r7j-CQ5OBWfzuKzNfgz1MJQWuUgE62gLltNd-QjVNVphNZHLEeVS4v4sj_-MLnwaYIURVqHcRo9iRyZ-U9037r3h_uI61ecjz9-3Tvw3YQBX8dhNPMzXvFQF2lVVFInaPygwxYnUlcCD1aE1G1ciNJEURmIMpGove10XvQRCi5KZBbc9xbcTqNUEo_JvWV6SRZmwVDzlcqYDxHVSI46VByUb4SOG1ocmZ-s6MSrmuEf1XglVmtV4Pge3HW2K9vtie0-rJnmAWwcu-j8Q_jdt0LuWFsxaoPs131-_GzOaptaiYuHkRRsSH5ndBPM0OknQxYpcAlRN2xCNSloDTNNr6bMdYHtGJW-Tb-3BDbNy9qVkc3fsRyfm7L9Uf_CrV0e_jn-tNNJHsHpjeDnMaw3bWM2gYkiCLURMk9kILQocyHSCs0habTJM156EAw4UNq1R6cDnysbpo-k6tGmEG2K0KYSD94slkz63iDXAe8QYlVf3rqQK2oXDeosIbPZg9cWgiQL_rPOXYEEfj_16FqB3F6BRImgV18PxKOcROrUkn88eLF4TSspy64x7SXCCIqzE-l68KQnusXBIp6irR8LD94OVLjc_L-nfnr9p-zABjKx-nx4crQFdzilC9n0vm1Yn00vzTO092bFc8tYDL7dNCf_BWqEYyc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+high-intensity+interval+training+compared+with+resistance+training+in+prostate+cancer+patients+undergoing+radiotherapy%3A+a+randomized+controlled+trial&rft.jtitle=Prostate+cancer+and+prostatic+diseases&rft.au=Piraux%2C+Elise&rft.au=Caty%2C+Gilles&rft.au=Renard%2C+Laurette&rft.au=Vancraeynest%2C+David&rft.date=2021-03-01&rft.pub=Nature+Publishing+Group&rft.issn=1365-7852&rft.volume=24&rft.issue=1&rft.spage=156&rft_id=info:doi/10.1038%2Fs41391-020-0259-6&rft.externalDocID=A656964057 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1365-7852&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1365-7852&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1365-7852&client=summon |